Company Filing History:
Years Active: 2013
Title: **Kirsten Marie Jakobsen: Pioneering Innovations in Thrombin Assays**
Introduction
Kirsten Marie Jakobsen, a distinguished inventor based in Copenhagen, Denmark, has made significant contributions to the field of biochemistry through her innovative work on thrombin assays. With a keen focus on improving diagnostic techniques, she has secured her position as a prominent figure in scientific research and innovation.
Latest Patents
Kirsten holds a patent for a groundbreaking invention titled "Thrombin substrate and assay for determining the level of bioactive thrombin in a sample." This patent encompasses substrates for thrombin and various assays designed to accurately determine the concentration of bioactive thrombin in biological samples. The substrate is characterized by the general formula: A-X—Z-A', wherein one of either A or A' comprises a luminescent chelate, while the other includes a first partner of a binding pair. The component X forms a tri- or tetra-peptide, and Z consists of a linker. This innovative approach enhances the sensitivity and specificity of thrombin detection critical for various medical applications.
Career Highlights
Kirsten is associated with Radiometer Medical Aps, a company known for its commitment to advancing medical diagnostics. Her efforts in developing advanced assays have led to improved methodologies for analyzing thrombin levels, thereby facilitating better healthcare outcomes. Her work exemplifies the blend of scientific inquiry and practical application, marking significant milestones in her career.
Collaborations
Throughout her career, Kirsten has collaborated with skilled professionals in her field, including colleagues Qiu-Ping Qin and Harri Takalo. These partnerships have fostered a rich environment for innovation, enabling the sharing of ideas and expertise that enhance research outcomes and contribute to the overall advancement of medical diagnostics.
Conclusion
Kirsten Marie Jakobsen stands out as a leading figure in the field of biochemistry and diagnostics. Her patent on thrombin substrates and assays highlights her innovative spirit and dedication to enhancing medical technologies. Through her work at Radiometer Medical Aps and her collaborative efforts, she continues to pave the way for future breakthroughs in the evaluation and treatment of health conditions associated with thrombin.